Free Trial

Virios Therapeutics (VIRI) Short Interest Ratio & Short Volume

$0.26
-0.03 (-10.24%)
(As of 07/18/2024 ET)

Virios Therapeutics Short Interest Data

Current Short Interest
312,200 shares
Previous Short Interest
570,300 shares
Change Vs. Previous Month
-45.26%
Dollar Volume Sold Short
$67,123.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
19,260,000 shares
Percentage of Shares Shorted
1.62%
Today's Trading Volume
12,630,858 shares
Average Trading Volume
1,052,861 shares
Today's Volume Vs. Average
1,200%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Virios Therapeutics ?

Sign up to receive the latest short interest report for Virios Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VIRI Short Interest Over Time

VIRI Days to Cover Over Time

VIRI Percentage of Float Shorted Over Time

Virios Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2024312,200 shares $67,123.00 -45.3%N/A0.3 $0.22
6/15/2024570,300 shares $135,845.46 +70.1%N/A0.5 $0.24
5/31/2024335,300 shares $72,156.56 +233.6%N/A0.3 $0.22
5/15/2024100,500 shares $40,853.25 -57.9%N/A0.2 $0.41
4/30/2024238,500 shares $108,016.65 +11.2%N/A0.8 $0.45
4/15/2024214,500 shares $101,029.50 -1.4%N/A0.7 $0.47
3/31/2024217,500 shares $104,204.25 +27.8%N/A0.6 $0.48
3/15/2024170,200 shares $54,123.60 +76.9%N/A0.5 $0.32
2/29/202496,200 shares $35,690.20 -36.8%N/A0.4 $0.37
2/15/2024152,300 shares $58,787.80 +67.4%N/A0.6 $0.39
1/31/202491,000 shares $37,310.00 -59.5%N/A0.3 $0.41
1/15/2024224,900 shares $170,699.10 +1.5%N/A0.5 $0.76
12/31/2023221,600 shares $127,420.00 -12.6%N/A0.5 $0.58
12/15/2023253,400 shares $169,651.30 -13.0%N/A0.6 $0.67
11/30/2023291,100 shares $165,635.90 -35.8%N/A0.7 $0.57
11/15/2023453,700 shares $333,197.28 +308.7%N/A1 $0.73
10/31/2023111,000 shares $61,050.00 -42.7%N/A0.2 $0.55
10/15/2023193,800 shares $154,071.00 -30.4%N/A0.5 $0.80
9/30/2023278,500 shares $257,556.80 -33.4%N/A0.5 $0.92
9/15/2023418,400 shares $435,136.00 -10.0%N/A0.7 $1.04
8/31/2023465,100 shares $511,610.00 -17.9%N/A0.7 $1.10
8/15/2023566,300 shares $577,626.00 -4.0%N/A0.7 $1.02
7/31/2023589,800 shares $1.12 million +16.2%N/A0.8 $1.90
7/15/2023507,600 shares $1.23 million +52.1%N/A0.2 $2.42
6/30/2023333,700 shares $460,506.00 -36.4%N/A0.1 $1.38
6/15/2023524,500 shares $970,325.00 +26.6%N/A0.2 $1.85
5/31/2023414,300 shares $712,596.00 +26.5%N/A0.1 $1.72
5/15/2023327,500 shares $337,325.00 -68.8%N/A0.1 $1.03
4/30/20231,050,000 shares $766,500.00 +95.9%N/A0.4 $0.73
4/15/2023536,100 shares $364,548.00 +45.3%N/A0.2 $0.68
3/31/2023368,900 shares $135,570.75 +0.0%N/A0.6 $0.37
3/15/2023368,800 shares $111,857.04 +52.5%N/A0.8 $0.30
2/28/2023241,900 shares $72,570.00 +18.3%N/A0.6 $0.30
2/15/2023204,500 shares $69,100.55 -23.6%N/A0.6 $0.34
1/31/2023267,700 shares $82,612.22 +25.6%N/A0.8 $0.31
1/15/2023213,100 shares $59,028.70 +4.0%N/A0.7 $0.28
12/30/2022205,000 shares $48,380.00 -42.5%N/A0.7 $0.24
12/15/2022356,400 shares $92,664.00 +20.8%N/A1.1 $0.26
11/30/2022295,100 shares $85,579.00 -33.2%N/A0.4 $0.29
11/15/2022441,500 shares $136,865.00 +55.7%N/A0.6 $0.31
AI’s Biggest Problem (Ad)

Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.

Find out more details on these three critical Nvidia partners immediately.
10/31/2022283,600 shares $77,990.00 -34.4%N/A0.4 $0.28
10/15/2022432,600 shares $154,438.20 +8.7%N/A0.7 $0.36
9/30/2022398,100 shares $151,477.05 +526.9%4.8%0.7 $0.38
9/15/202263,500 shares $492,760.00 +18.0%0.8%0.1 $7.76
8/31/202253,800 shares $380,366.00 +6.8%1.0%2.2 $7.07
8/15/202250,400 shares $422,352.00 +5.2%0.9%2.2 $8.38
7/31/202247,900 shares $335,300.00 +5.7%0.9%2.8 $7.00
7/15/202245,300 shares $256,851.00 -4.2%0.8%2.6 $5.67
6/30/202247,300 shares $200,079.00 -1.5%0.9%3.1 $4.23
6/15/202248,000 shares $193,920.00 +5.7%0.9%2.7 $4.04
5/31/202245,400 shares $194,766.00 +1.3%0.9%2.4 $4.29
5/15/202244,800 shares $158,144.00 +5.7%0.9%2.2 $3.53
4/30/202242,400 shares $170,024.00 -7.6%0.8%2.4 $4.01
4/15/202245,900 shares $195,593.67 -1.7%0.9%2.3 $4.26
3/31/202246,700 shares $209,216.00 -6.6%0.9%2 $4.48
3/15/202250,000 shares $250,500.00 +1.8%1.0%2.1 $5.01
2/28/202249,100 shares $277,906.00 -9.2%0.9%2.1 $5.66
2/15/202254,100 shares $342,994.00 -11.6%1.0%2.2 $6.34
1/31/202261,200 shares $391,680.00 -4.4%1.2%2.1 $6.40
1/15/202264,000 shares $407,040.00 -1.2%1.2%1.9 $6.36
12/31/202164,800 shares $331,776.00 -16.9%1.2%2.1 $5.12
12/15/202178,000 shares $383,760.00 -2.1%1.5%2.7 $4.92
11/30/202179,700 shares $434,365.00 -14.9%1.5%2.8 $5.45
11/15/202193,600 shares $509,184.00 +34.1%1.8%3 $5.44
10/29/202169,800 shares $325,966.00 -0.6%1.3%2.3 $4.67
10/15/202170,200 shares $329,940.00 -6.9%1.3%2.9 $4.70
9/30/202175,400 shares $398,866.00 -2.8%1.4%2.3 $5.29
9/15/202177,600 shares $426,800.00 -6.5%1.1%2.1 $5.50
8/31/202183,000 shares $419,980.00 +11.7%4.0%1 $5.06
8/13/202174,300 shares $375,215.00 -3.3%3.5%0.8 $5.05
7/30/202176,800 shares $456,960.00 +1.1%1.5%0.5 $5.95
7/15/202176,000 shares $464,360.00 -7.0%1.4%0.5 $6.11
6/30/202181,700 shares $513,893.00 -16.2%1.5%0.5 $6.29
6/15/202197,500 shares $555,750.00 +0.6%1.8%0.6 $5.70
5/28/202196,900 shares $508,725.00 -0.5%1.8%0.8 $5.25
5/14/202197,400 shares $458,754.00 -10.8%1.4%0.7 $4.71
4/30/2021109,200 shares $634,452.00 -16.4%1.5%1 $5.81
4/15/2021130,600 shares $770,540.00 +1.7%1.9%0.8 $5.90
3/31/2021128,400 shares $731,880.00 +9.6%1.8%0.6 $5.70
3/15/2021117,200 shares $772,348.00 +57.5%1.8%0.3 $6.59
2/26/202174,400 shares $471,696.00 +3.9%1.1%0.1 $6.34
2/12/202171,600 shares $539,148.00 +24.1%1.1%0.1 $7.53
1/29/202157,700 shares $413,709.00 +18.5%0.9%0.1 $7.17
1/15/202148,700 shares $406,158.00 No Change0.7%0 $8.34

VIRI Short Interest - Frequently Asked Questions

What is Virios Therapeutics' current short interest?

Short interest is the volume of Virios Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 312,200 shares of VIRI short. Learn More on Virios Therapeutics' current short interest.

Is Virios Therapeutics' short interest increasing or decreasing?

Virios Therapeutics saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 312,200 shares, a decline of 45.3% from the previous total of 570,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Virios Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Virios Therapeutics: Indaptus Therapeutics, Inc. (0.10%), MEI Pharma, Inc. (0.29%), Conduit Pharmaceuticals Inc. (0.71%), Synlogic, Inc. (0.13%), Apollomics, Inc. (0.31%), Sensei Biotherapeutics, Inc. (1.71%), Unicycive Therapeutics, Inc. (5.29%), BriaCell Therapeutics Corp. (3.64%), Aytu BioPharma, Inc. (7.16%), Kintara Therapeutics, Inc. (5.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Virios Therapeutics stock?

Short selling VIRI is an investing strategy that aims to generate trading profit from Virios Therapeutics as its price is falling. VIRI shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Virios Therapeutics?

A short squeeze for Virios Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRI, which in turn drives the price of the stock up even further.

How often is Virios Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRI, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:VIRI) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners